Viewing Study NCT04202003


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-02-02 @ 2:17 PM
Study NCT ID: NCT04202003
Status: COMPLETED
Last Update Posted: 2024-04-15
First Post: 2019-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Sponsor: TJ Biopharma Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia (AML) View
None Myelodysplastic Syndromes(MDS) View
Keywords: